Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




U.S. Panel Backs Proposed J&J Psoriasis Drug
Link ID 6802
Title U.S. Panel Backs Proposed J&J Psoriasis Drug
Url http://www.medscape.com/viewarticle/576306?src=rss
Description An experimental Johnson & Johnson drug should be approved for treating adults with moderate or severe psoriasis, a advisory panel unanimously ruled Tuesday. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Jun 20, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Perspectives on Methicillin-resistant Staphylococcus aureus: The Persistent Pathogen
  MRSA persists as a costly threat. Read updates on prevalence, prevention, and treatment from the ATS 2008 meeting.
Medscape Pulmonary Medicine
Category:   Articles > Business of Medicine


2. Post-Op Ileus Drug Safety Unclear: FDA Staff
  A U.S. regulatory review of a drug to treat post-operative ileus (POI) found that the subsequent MI rate was similar to that seen with placebo, but the investigators said no conclusion could be drawn because of limited patient follow-up. Reuters Health Information
Category:   Articles > Business of Medicine


3. Ancillary Services for Cardiology
  Cardiologists are finding that while the ancillary services can provide good patient care, they vary in profitability, cost, and effort.
Medscape Business of Medicine
Category:   Articles > Business of Medicine


4. A Closer Look at Pressure Ulcers
  A new Medicare rule going into effect late in 2008 will make the assessment, staging, and prevention of pressure ulcers more important than ever -- how will this affect you? Medscape Nurses
Category:   Articles > Business of Medicine


5. Cigna Fourth-Quarter Profit Rises 13 Percent
  Insurer Cigna Corp said on Wednesday that fourth-quarter profit rose 13 percent, as its international operations and disability and life segment offset weaker performance in its main health care business. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS